Share this post on:

Product Name :
Spartalizumab Biosimilar, PD-1 Monoclonal Antibody

EN
programmed cell death protein 1, PD1, CD279, cluster of differentiation 279

Source:
The anti-human PD-1 monoclonal antibody spartalizumab biosimilar was produced in mammalian cells.

Molecular Weight:

Activity :

Purity:
>95% by SDS-PAGE under reducing conditions and HPLC.

Endotoxin :
< 1 EU per 1 mg of the protein by the LAL method.

Formulation:

Reconstitution :

Shipping:
The research grade spartalizumab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage:
/strong>Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

Form of Antibody :
0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.

Clone:

Isotype:
Human IgG4 kappa.

Background:
Spartalizumab Biosimilar uses the same protein sequences as the therapeutic antibody spartalizumab. A humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1), with immune checkpoint inhibitory and antineoplastic activities. Upon administration, spartalizumab binds to PD-1 expressed on activated T cells and blocks the interaction with its ligands, programmed cell death 1 ligand 1 (PD-L1, PD-1L1) and PD-1 ligand 2 (PD-L2, PD-1L2). The inhibition of ligand binding prevents PD-1-mediated signaling and results in both T-cell activation and the induction of T-cell-mediated immune responses against tumor cells. PD-1, an immunoglobulin (Ig) superfamily transmembrane protein and inhibitory receptor, negatively regulates T-cell activation. Syd Labs provides the following research grade anti-PD-L1 / PD-1 antibody biosimilar proteins: Atezolizumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody Avelumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody Camrelizumab biosimilar, research grade, anti-human PD-1 monoclonal antibody Cemiplimab biosimilar, research grade, anti-human PD-1 monoclonal antibody Durvalumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody Nivolumab biosimilar, research grade, anti-human PD-1 monoclonal antibody Pembrolizumab biosimilar, research grade, anti-human PD-1 monoclonal antibody Spartalizumab biosimilar, research grade, anti-human PD-1 monoclonal antibody PD-1 is a member of the extended CD28/CTLA-4 family of T cell regulators. Syd Labs provides the following research grade anti-CTLA-4 antibody biosimilars: Ipilimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody Tremelimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody Syd Labs provides the following anti-mouse PD-L1 / PD-1 antibodies: In vivo grade recombinant anti-mouse PD1 monoclonal antibodies (Clone 29F.1A12.1) In vivo grade recombinant anti-mouse PD-1 monoclonal antibodies (Clone RMP1-14.1) In vivo grade recombinant anti-mouse PD-L1 monoclonal antibodies (Clone 10F.9G2.1)

Additional Information:
| S|Human IgG4 kap|The anti-human PD-1 monoclonal antibody s|The in vivo grade s|ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological |0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives. |Endotoxin: |Purity: >95% by SDS-|The research grade s|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |Background S|Atezolizumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody Avelumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody Camrelizumab biosimilar, research grade, anti-human PD-1 monoclonal antibody Cemiplimab biosimilar, research grade, anti-human PD-1 monoclonal antibody Durvalumab biosimilar, research grade, anti-human PD-L1 monoclonal antibody Nivolumab biosimilar, research grade, anti-human PD-1 monoclonal antibody Pembrolizumab biosimilar, research grade, anti-human PD-1 monoclonal antibody S|Ipilimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody Tremelimumab Biosimilar, research grade, anti-human CTLA-4 monoclonal antibody Syd Labs provides the following anti-mouse PD-L1 / PD-1 antibodies: In vivo grade recombinant anti-mouse PD1 monoclonal antibodies (Clone 29F.1A12.1) In vivo grade recombinant anti-mouse PD-1 monoclonal antibodies (Clone RMP1-14.1) In vivo grade recombinant anti-mouse PD-L1 monoclonal antibodies (Clone 10F.9G2.1)

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
APG5L Antibody
Ki-67 Antibody
PKC eta Antibody: PKC eta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC eta. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: signsin1dayinc